Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy

American Journal of Cardiology

Volumn 92, Issue 11, 2003, Pages 1350-1354

  Lund, Lars H ^b   Aaronson, Keith D ^b   Mancini, Donna M ^a  

^a Division of Circulatory Physiology   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PARAMETER; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE;

EID: 0242404683     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.08.027     Document Type: Article

References (13)

1. Mancini D., Eisen H., Kussmaul W., Mull R., Edmunds L.H., Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786.
2. Aaronson K., Mancini D. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? J Heart Lung Transplant. 14:1995;981-989.
3. Aaronson K., Schwartz J.S., Chen T., Wong K., Goin J., Mancini D. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 95:1997;2660-2667.
4. Deng M.C., De Meester J.M., Smits J.M., Heinecke J., Scheld H.H. Effect of receiving a heart transplant analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group . Br Med J. 321:2000;540-545.
5. Zugck C., Kruger C., Kell R., Korber S., Schellberg D., Kubler W., Haass M. Risk stratification in middle-aged patients with congestive heart failure prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model . Eur J Heart Fail. 3:2001;577-585.
6. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
7. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 334:1996;1349-1355.
8. Zugck C., Haunstetter A., Kruger C., Kell R., Schellberg D., Kubler W., Haass M. Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol. 39:2002;1615-1622.
9. Hulsmann M., Sturm B., Pacher R., Berger R., Bojic A., Frey B., Stanek B. Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction. J Heart Lung Transplant. 20:2001;1174-1180.
10. Gullestad L., Hallen J., Medbo J.I., Gronnerod O., Holme I., Sejersted O.M. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. Br J Clin Pharmacol. 41:1996;57-67.
11. Peterson L.R., Schechtman K.B., Ewald G.A., Geltman E.M., Meyer T., Krekeler P., Rogers J.G. The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J Heart Lung Transplant. 22:2003;70-77.
12. Pohwani A.L., Murali S., Mathier M.M., Tokarczyk T., Kormos R.L., McNamara D.M., MacGowan G.A. Impact of β-blocker therapy on functional capacity criteria for heart transplant listing. J Heart Lung Transplant. 22:2003;78-86.
13. Myers J., Gullestad L., Vagelos R., Do D., Bellin D., Ross H., Fowler M.B. Cardiopulmonary exercise testing and prognosis in severe heart failure 14 mL/kg/min revisited . Am Heart J. 139:2000;78-84.